Ten minutes of complete ischemia was pro duced in 11 dogs by temporary ligation of the aorta. Im mediately before the ischemic episode, the dogs received nimodipine, a new calcium entry blocker, 10 f-Lg kg-I, i.v., followed by an infusion of 1 f-Lg kg-1 min-1 for 2 h. Post ischemic cerebral blood flow and metabolism were mea sured for 120 min in six dogs. Neurologic recovery was evaluated 48 h post-ischemia in five dogs. The results were compared to previously determined controls. Ni modi pine nearly doubled cerebral blood flow in the de layed post-ischemic hypoperfusion period, compared to untreated dogs (approximately 45% versus 25% of pre-
When the circulation is reestablished after a peri od of complete cerebral ischemia, a transient 5-15min period of increased cerebral blood flow (CBF) is usually followed by a period of prolonged hypo perfusion (Hossman et aI., 1973; Snyder et aI., 1975; Siesjo, 1978; Steen et aI., 1978) . It has been specu lated that the magnitude of the ultimate neurologic damage is due at least in part to this hypoperfusion period, and not simply to the initial ischemic insult (Bleyaert et aI. , 1978; Siesjo, 1978) .
Calcium entry blockers have been found to dilate cerebral vessels (Allen and Banghart, 1979; Allen and Rahn, 1979; Edvinsson et aI. , 1979; Hoffmeister et aI., 1979; Shimizu et aI., 1980; Harper et aI., 1981) , and a preliminary report indicates that the calcium entry blocker nimodipine greatly improves CBF after complete cerebral ischemia in cats (Hoffmeister Dr. Steen is visiting scientist from Ulleval Hospital, Oslo, Norway.
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ischemic control values), but had no significant effect on metabolism. Nimodipine also improved neurologic re covery. Four of five treated dogs were normal and one was moderately damaged, whereas six of seven controls were either severely damaged or dead. This suggests that the delayed hypoperfusion state occurring after com plete cerebral ischemia probably does contribute to the ultimate neurologic damage, and that nimodipine offers a potential protective effect. Key Words: Calcium entry blocker-Cerebral protection-Complete cerebral isch emia-Nimodipine. et aI. , 1979) . The effects of nimodipine on CBF, cerebral metabolism, and neurologic outcome were therefore studied in an established canine model of complete cerebral ischemia.
MATERIALS AND METHODS
Eleven unmedicated, fasting adult mongrel dogs, weighing 10.7 to 12.0 kg, were studied in the prone posi tion. Six dogs were used to study the effect of nimodipine on CBF and cerebral metabolism (CMR02) given both before and after 10 min of complete cerebral ischemia. Five dogs similarly treated with nimodipine were evalu ated for neurologic function 48 h post-ischemia. The re sults were compared to those previously established for untreated groups (Steen et aI., 1978 (Steen et aI., , 1979a . Each sub group of dogs given nimodipine was otherwise managed identically to its comparable subgroup of control dogs.
In the six dogs used to study CBF and CMR02, anes thesia was induced and maintained throughout the surgi cal procedure with 1% halothane in 60-70% nitrous oxide and oxygen. Succinylcholine, 2 mg kg-I, was given i.v. to facilitate endotracheal intubation, and thereafter was continuously infused (7.5 mg kg-I h-I) to maintain muscle paralysis. Ventilation was controlled with a Harvard pump and kept constant after initial adjustment to hold Pac02 close to 38 mm Hg. The surgical procedure required 20-30 min, whereafter halothane was discontinued for at least 20 min before initiating control measurements. Can nulae were inserted into a femoral artery for blood sam-piing and continuous monitoring and intermittent record ing of arterial pressure, and in a femoral vein for drug and fluid administration. Through a right-sided thoracotomy in the fourth interspace, umbilical tapes were placed around the ascending aorta, inferior vena cava, and supe rior vena cava above the azygos vein. After hepariniza tion (300-400 units kg-I, i.v.), the sagittal sinus was ex posed, isolated, and cannulated as previously described for direct measurements of CBF from anterior, superior, and lateral portions of both hemispheres (equal to ap proximately 54% of the total brain weight) (Michenfelder et aI., 1968; Takeshita et aI., 1972) . A four-lead bilateral electroencephalogram (EEG) was obtained with elec trodes glued to the skull. Body temperature was mea sured with an esophageal thermistor and brain tempera ture with a parietal epidural thermistor, both maintained at 37.0 ± O.I°C by the use of heat lamps as needed. Paoz, Pac02, pH, and sagittal sinus P02 (Pssoz) were determined by I.L. (Instrumentation Laboratories) electrodes at 37°C. Blood oxygen contents were calculated from measure ments of oxyhemoglobin concentrations (l.L. 282 CO ox imeter) and O2 tensions. Cerebral metabolic rate for oxy gen was calculated as the product of CBF and arterial sagittal sinus blood Oz-content differences (A VDOz).
After obtaining pre-ischemic measurements of CBF and CMROz, nimodipine, 10 f.Lg kg-I, was given, and 2 min later complete cerebral ischemia lasting exactly 10 min was achieved by a previously described method (Steen et al. 1978 . The umbilical tapes placed around the ascending aorta, inferior vena cava, and supe rior vena cava were simultaneously occluded, confining cardiac outflow to coronary and pulmonary circulation. The sagittal sinus cannula was likewise occluded during this time to avoid aspiration of air. In all dogs, the EEG became isoelectric within 45 s of occlusion. When the EEG was rendered isoelectric, nitrogen was substituted for nitrous oxide in the inspired gas for the rest of the study. After 10 min, the tape around the aorta was re leased, the tapes around the venae cavae having been released 15 -20 s earlier. Nimodipine was continued at an infusion rate of 1 f.Lg kg-I min -I following ischemia. CBF and CMROz were measured during a 120-min period post-ischemia, whereafter the dura overlaying the cere bral hemispheres was excised, and cortical biopsies were taken by a technique that deposits a sample of brain (200-400 mg) into liquid nitrogen within 1 s (Kramer et aI., 1968) . The tissue was stored at -76°C and prepared for analysis in a refrigerated box ( -25°C) as described by Folbergrova et al. (1972) . Tissue extracts were analyzed by enzymatic fluorometric techniques for phospho creatine (PCr), ATP, ADP, AMP, glucose (Lowry and Pas sonneau, 1972) , and lactate and pyruvate (Lowry et aI., 1964) . (Atkinson, 1968) .
Five dogs were used for neurologic functional studies following 10 min of complete cerebral ischemia. In these dogs, anesthesia was induced and maintained with 70% nitrous oxide and oxygen. The inspired gas was changed to 100% oxygen 5 min pre-ischemia and to room air 20 min post-ischemia. Intubation, ventilation, femoral, ven-ous, and arterial cannulations, and thoracotomy were performed as in the previous group, but 20 ml 0.5% pro caine was infiltrated into the chest wall before the thoracotomy, and succinylcholine was given only to facilitate intubation, 2 mg/kg. In these dogs, a four-lead EEG was recorded with needle electrodes. Body temper ature was maintained at 37.4 ± 0.2°C by the use of heat lamps and electrically heated blankets, as needed. Nimodipine, 10 f.Lg kg-I, was given 2 min before ischemia, and an infusion of I f.Lg kg-I min-1 was continued for 180 min post-ischemia. After the ischemic episode, the thoracotomy was closed. Arterial blood gases were mea sured before ischemia and at regular intervals afterward. Ventilation was controlled until spontaneous ventilation was deemed adequate (Pacoz < 45 mm Hg). The dogs were then extubated and observed.
Forty-eight hours post-ischemia, the dogs were evalu ated neurologically and assigned to one of four groups. Grade 1 (no damage) dogs ate and behaved normally and their movements were fully coordinated. Grade 2 (moder ate damage) dogs could stand alone, but were ataxic or exhibited partial or complete blindness. Grade 3 (severe damage) dogs could not stand alone or were comatose. Grade 4 (dead) dogs died within 48 h. The dogs were then killed and at necropsy the thorax was examined to assess any gross post-thoracotomy complications.
For statistical comparison of the neurologic outcomes between dogs in the present study and control dogs from a previous study (Steen et aI., 1979a) exposed to 10 min of complete ischemia, the Fisher exact test was used. For all other comparisons between treated and untreated dogs, Student's t test for unpaired data was used. For compari son between pre-and post-ischemic values in the same group, Student's t test for paired data was used. A p value less than 0.05 was regarded as significant. All mean values are reported with the standard error of the mean (SEM).
RESULTS

CBF and metabolic studies
There were no significant differences in blood gases between nimodipine-treated and untreated dogs at any time pre-or post-ischemia, except for a lesser degree of arterial and sagittal sinus oxygena tion in treated dogs 1 min post-ischemia and less metabolic acidosis in the same group 90 min post ischemia (Table 1) . P aC02 was significantly in creased and pH decreased 1 min post-ischemia in both groups, due to the build-up of CO2 and lactate in the tissues during the ischemic period. Carbon dioxide was normalized within the first 10 min post-ischemia. In untreated dogs, mean arterial pressure (MAP) was normalized within 1 min post-ischemia. In treated dogs, MAP stayed signifi cantly below pre-ischemic values the first 4 min post-ischemia, with no significant difference be tween the two groups thereafter. MAP gradually a Significantly different from "no nimodipine" values taken from Steen et al. (1978) .
/, Significantly different from pre-ischemia values.
declined in both groups to below pre-ischemic val ues within 20 min post-ischemia. The 90-min values are thus representative for the rest of the post ischemic period. There was no difference in CBF between the two groups in the preischemic situation; CBF increased in both groups during the first 10 min post-ischemia (Fig. 1) , and was significantly higher for the un treated dogs 2 and 3 min post-ischemia. Thereafter, CBF gradually declined and stayed significantly below pre-ischemic values in both groups, begin ning 25 min post-ischemia. However, in the nimodipine-treated group, CBF was significantly greater than in the untreated group for the remain ing 95 min. There was no significant difference in CMR02, at any point, between the two groups (Fig.  2 ). If cerebrovascular resistance (CVR) is calcu lated, there is no significant difference between treated and untreated dogs pre-or immediately post-ischemia. The combination of lower MAP and lower CBF in the treated dogs the first few minutes post-ischemia gives a CVR equal to that of the un treated dogs. For the period after 20 min post ischemia, in which CBF was continuously higher in the treated dogs, mean MAP was continuously higher in untreated dogs numerically (not signifi cantly different); thus, the relative difference in CVR between the two groups more than 20 min post-ischemia was always equal to or greater than the difference in CBF. The EEG became isoelectric at 35 ± 2 versus 23 ± 4 s after circulatory arrest for untreated versus treated dogs, significantly sooner for treated dogs, and returned at 18 ± 3 and 17 ± 4 min post ischemia.
There were no significant differences in cerebral metabolite levels between treated and untreated dogs ( Table 2) .
Neurologic studies
The neurologic status of the dogs at 48 h post ischemia was significantly better in the group that received nimodipine, compared to the controls (Table 3) . Six of seven controls were severely dam aged or dead 48 h post-ischemia, whereas four of five treated dogs appeared normal and one was moderately damaged. These differences could not be accounted for by any differences in blood gases between the two groups, either prior to ischemia or at the time of extubation (Table 4) .
DISCUSSION
It has been speculated that the delayed hypoper fusion state that occurs after a period of complete cerebral ischemia is a major factor contributing to the ultimate neurologic damage that occurs (Bleyaert et aI., 1978; Siesjo, 1978) . Bleyaert et aI. (1978) reported that barbiturates reduced the mag nitude of neurologic deficits when given after a pe riod of complete ischemia, although subsequent studies (Gis void et aI. , 1981) from the same labora tory have indicated that the difference in results was possibly due to better post-ischemic care and blood pressure control in the treated group rather than to the barbiturates per se. Harper et aI. (1981) reported that in normal ba boons nimodipine is a modest cerebral vasodilator when given at a constant infusion of 2 p.,g kg-1 min-I, without having an effect on cerebral metabo lism. Moreover, when the blood-brain barrier was osmotically disrupted, nimodipine proved to be a potent cerebral vasodilator-again, without meta bolic effects. They speculated that in ischemic brain regions, where blood-brain barrier dysfunction can be anticipated, nimodipine might have important beneficial effects.
Other calcium entry blockers have been found to be effective cerebral vasodilators in other models. Shimizu et aI. (1980) found in vitro that nifedipine, verapamil, and diltiazem caused a dose-related re laxation of spasm induced in canine cerebral ar teries by potassium or prostaglandins. For the prostaglandin-induced spasm, the effect of verapa mil on the cerebral arteries was significantly greater than on coronary or mesenteric arteries. Allen and Banghart (1979) found similar effects for verapamil when comparing canine basilar and femoral ar teries; and nifedipine was found to be effective in reducing the magnitude of experimentally induced chronic or acute cerebral vasospasms in dogs in vivo (Allen and Rhan, 1979) and in human arteries in vitro (Edvinsson et aI. , 1979) .
It is possible that the hypoperfusion state, which (as in the present study) generally starts 15-30 min post-ischemia (Hossmann et aI., 1973; Snyder et aI. , 1975; Siesjo, 1978; Steen et aI. , 1978a) , is due to an increase in calcium influx into the potassium de polarized vascular smooth muscle (Hoffmeister et aI. , 1979) . This could explain how the calcium entry blocker nimodipine increased CBF during this pe riod in the present study. Although the hypoperfu sion state was not completely corrected, the trend was the same as that reported from the manufac turer's laboratory study (Hoffmeister et aI., 1979) , in which oral nimodipine, 1 mg kg-I, completely Steen et al. (1978) , for which the post-ischemic biopsies were taken after 90 min. In the same study, other biopsies were taken after 180 and 360 min, showing no change in EC, glucose or lactate levels, or lactate/pyruvate, whereas PCr and ATP levels tended to increase gradually with time. Thus, it should be appropriate to compare the 90-min values from the previous study with present biopsies taken 120 min post-ischemia.
Abbreviations used: PCr, phosphocreatine; EC, energy charge. abolished the 40% decrease in CBF otherwise seen in control cats after 7 min of cerebral ischemia ob tained by a 1.7-atm neck tourniquet. Likewise, an improvement in CBF after 20 min of circulatory ar rest in dogs was reported by White et al. (1982) for the calcium entry blocker flunarizine. Neither of these studies correlated the circulatory effects with neurologic outcome, and although it is interesting that flow can be improved even after 20 min of ar rest, the clinical significance was not established.
Although there was no significant difference in CMR02 between the two groups at any time post ischemia, mean CMR02 was numerically higher throughout the period in the treated dogs. This makes the ratio of CBF to CMR02 less different than the difference in CBF between the two groups. It can be argued that the extent to which nimodipine can be shown to prevent vasoconstriction in the hypoperfusion period is the extent to which CBFI CMR02 increases compared to the untreated dogs. Therefore, the effect of nimodipine on the post ischemic hypoperfusion would be less striking than when judged from the CBF and CVR values alone. Thus, PSSo2 was not significantly different between the two groups post-ischemia, and nimodipine ap parently did not change the ratio of oxygen supply to oxygen use. On the other hand, it can be argued that the possible prevention of vasoconstriction can be judged only from the CBF and CVR values alone. If there is a primary reduction in CBF in this period that is harmful to the brain, it seems more likely that the metabolic rate is determined by the blood flow-not the other way around. Thus, the smaller difference in CBFICMR02 than in CBF val ues between the two groups might indicate only that the treated dogs tend to use more oxygen because the untreated brain was hypoxic, and increasing the oxygen supply with nimodipine increases CMR02, or, simply, that the dogs given nimodipine have less brain damage and thus a better sustained brain function, which requires more oxygen. The latter arguments are supported by findings of a previous study in which 10 min of severe incomplete isch emia both improved neurologic outcome and in creased CMR02 post-ischemia, when compared to complete ischemia (Steen et al. , 1979b) . The third and simplest explanation can be found in the pre ischemic values. Pre-ischemia CMR02 was numeri cally lower, and CBFICMR02 numerically higher, in the untreated dogs. Thus, if CBFICMR02 post ischemia is expressed as a ratio of the pre-ischemic values, CBFICMR02 post-ischemia increases just as much as does CBF with nimodipine.
The lack of a difference in cerebral cortical me tabolite levels indicates that these levels are not a very sensitive indicator for neurologic damage. This agrees with numerous previous studies (Mrsulja et aI. , 1976; Levy and Duffy, 1977; Steen et al, 1979b) .
Although nimodipine improved CBF in the post-ischemic hypoperfusion period, it has never TABLE 4. Mean arterial pressure (MAP). hemoglobin (Hb) and arterial blood gases pre-ischemia and at the time of extubation for dogs followed for 48 h in neurologic studies (means ± SEM) been established that this hypoperfusion state con tributes to the ultimate cerebral damage. It seems entirely possible that the CBF, albeit low, is ade quate for the existing metabolic needs during the post-ischemic period and will adjust according to changes in those metabolic needs. Thus, in previous studies, barbiturates were found to reduce the post-ischemic metabolic needs of the brain, but this was accompanied by a comparable decrease in CBF and there was no difference in neurologic re covery (Steen et a!. , 1978 (Steen et a!. , , 1979a . The observation that nimodipine improved the neurologic outcome was therefore of great interest. First, this suggests that nimodipine may be a useful therapeutic agent in situations of complete cerebral ischemia. Second, this strongly suggests that the delayed post-ischemic hypoperfusion state does cause further neurologic damage, since an im proved CBF during this period was the only appar ent effect of nimodipine, although other effects that were not looked for cannot be excluded.
In conclusion, nimodipine improved CBF during the delayed post-ischemic hypoperfusion period as well as the neurologic outcome after 10 min of com plete cerebral ischemia in the dog.
